Chinese drug sector’s stature grows at major cancer conference

An array of Chinese drug makers showcased positive trial results for new cancer treatments at a major European medical conference, underscoring the expanding international influence of China’s biotech sector. Domestic innovative drugs, particularly antibody-drug conjugates (ADCs), delivered impressive data across mu…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.